Enabling API connection with telemedicine platforms from healthcare providers and improving the overall user experience
SAN DIEGO, January 04, 2022 (GLOBE NEWSWIRE) – GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”) is currently developing a mobile application for its AI-based health counseling system.
The mobile application will work with a back-end infrastructure, allowing an efficient and user-friendly interface. The mobile application will support private accounts, with a question-and-answer conversation type counseling system, and in future versions, support for natural voice using NLP (Natural Language Processing) technology. Mobile technology will be synchronized with the system’s web application for easier and more intuitive user interactions. The AI health counseling system will be formed with health-related information and connected to accredited data sources including the Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), medical manuals and other credible sources. Resources. The system aims to function as a general health question-and-answer counseling system, providing first-line medical advice.
GBT plans to further develop the system to include smart telemedicine capabilities that will help patients and healthcare specialists through connected devices. The AI-driven computer program will be able to connect to the computer systems of healthcare providers via an API (Application Programming Interface); effectively, by establishing direct telemedicine communications. The mobile technology plans to integrate GBT’s vital qTerm device to enable the sharing of vital information in real time with a healthcare professional during telemedicine sessions. The mobile app will support both iOS and Android platforms and is expected to be completed in the second quarter of 2022.
“As a natural evolution of our AI-based health counseling system, we are currently developing its mobile app to work with full synchronization with its web interface. Similar to the system’s web application, the mobile application will provide a type of conversational interface, designed to be at the forefront of an AI program that processes user data. The knowledge base health advisory system will be connected to credible health-related data resources, including the CDC, medical textbooks, and the NCBI, to provide credible advice on general health-related issues . Additionally, we plan to implement all the necessary infrastructure within the mobile app to establish future telemedicine capabilities with clinics and healthcare providers through an API interface. The architecture of the mobile application will include vital support for qTerm devices to enable future sharing of vital data in real time within telemedicine sessions. The goal of the health counseling worker is to provide first line health advice and to become a tool to help health professionals. One of its main advantages is the ability to provide medical assistance for remote locations. The design of the mobile application focuses on secure communication protocol, efficient data management and user-friendly interface. The mobile app will support both iOS and Android platforms, providing intelligent medical assistance, monitoring and telemedicine capabilities for our new era of healthcare, ”said Danny Rittman, CTO of the company.
There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise sufficient capital to support its research and, if researched and successfully developed, the Company will need to enter into a strategic relationship with a third party who has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company that considers itself native to the Internet of Things (IoT), intelligence artificial (AI) and activation Mobile technology platforms used to increase the performance of integrated circuits. GBT has assembled a team with extensive technological expertise and built an intellectual property portfolio made up of numerous patents. GBT’s mission is to license technology and intellectual property to synergistic partners in the areas of hardware and software. Once commercialized, GBT’s goal is to have a suite of products including smart chips, AI, encryption, blockchain, integrated circuit design, mobile security applications, management protocols. database, with tracking and cloud software support (without GPS). GBT envisions this system as the creation of a global mesh network using advanced nodes and high performance next generation IC technology. The heart of the system will be its advanced microchip technology; a technology that can be installed on any mobile or fixed device in the world. GBT’s vision is to produce this system as a low cost and secure private mesh network between all activated devices. Thus, providing advanced shared processing, management and sharing of mobile databases while using these enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to historical or current fact. Actual results may differ materially from those shown in these forward-looking statements due to various important factors as disclosed in our documents filed with the Securities and Exchange Commission located on their website (http://www.sec.gov). In addition to these factors, actual performance, results and future results may differ materially due to more general factors including (but not limited to) general industry and market conditions and growth rates. , economic conditions, changes in government and public policy, the Company’s ability to increase capital on acceptable terms, if applicable, the successful development of its products by the Company and integration into its existing products and l commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the opinions of the Company as of the date of this press release and such opinions could change. However, although the Company may choose to update these forward-looking statements at some time in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be taken as representing the views of the Company as of a date subsequent to the date of the press release.